跳至主要内容
临床试验/NCT04149626
NCT04149626Unknown2 期

Prospective, Randomized Comparative Study of Intravenous Dexmedetomidine for Sedation in Orthopedic Surgery Under Regional Anesthesia

Asklepieion Voulas General Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年1月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
60
试验地点
1
主要终点
Postoperative analgesia duration

研究概览

简要总结

60 patients ASA I-III, undergoing orthopedic surgery will be randomly assigned into one of three groups, namely group A (n=20), where dexmedetomidine will be used for sedation (initial bolus dose followed by continuous infusion), group B (n=20) where midazolam will be used for sedation (initial bolus dose followed by continuous infusion) and group C (n=20), where remifentanil will be used for sedation (initial bolus dose followed by continuous infusion). All patients will receive spinal anesthesia. Duration of postoperative analgesia, total dose of patient controlled IV morphine, sedation scores, nausea and vomiting, time of ambulation, sleep quality and patient satisfaction will be recorded for the first postoperative day. Additionally chronic pain on the site of surgery will be recorded in 3 and 6 months postoperatively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Physical status according to American Society of Anesthesiologists (ASA) I-III Patients scheduled for orthopedic surgery

排除标准

  • Patient denial, contraindication of spinal anesthesia or any of the agents used in the protocol, BMI above 30, Serious psychiatric, mental and cognitive disorders, Language barrier, illicit substances abuse,

研究组 & 干预措施

Group A

Active Comparator

Dexmedetomidine sedation

干预措施: Dexmedetomidine (Drug)

Group B

Active Comparator

Midazolam sedation

干预措施: Midazolam (Drug)

Group C

Active Comparator

Remifentanil sedation

干预措施: Remifentanil (Drug)

结局指标

主要结局

Postoperative analgesia duration

时间窗: 24 hours

Time of first demand for analgesia (PCA first bolus dose)

次要结局

  • Sedation(24 hours)
  • Postoperative pain: Numerical Rating Scale (NRS)(24 hours)
  • Morphine consumption(24 hours)
  • Rescue analgesia(24 hours)
  • Complications(24 hours)
  • Chronic pain: Graded Chronic Pain Scale (GCPS)(6 months)
  • Delirium occurence(24 hours)

研究者

发起方
Asklepieion Voulas General Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Alexandros Makris

Consultant Anesthesiologist

Asklepieion Voulas General Hospital

研究点 (1)

Loading locations...

相似试验

Dexmedetomidine Sedation in Orthopedic Surgery | 临床试验